• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.50% Nasdaq Down 2.41%

    Delcath Systems, Inc. (DCTH)

    -NasdaqCM
    0.23 Down 0.03(10.62%) Jun 27, 3:58PM EDT
    Prev Close:0.26
    Open:0.26
    Bid:N/A
    Ask:0.50 x 15000
    1y Target Est:1.00
    Beta:1.30273
    Earnings Date:Aug 3 - Aug 8 (Est.)
    Day's Range:0.23 - 0.26
    52wk Range:0.22 - 1.02
    Volume:651,358
    Avg Vol (3m):270,795
    Market Cap:5.56M
    P/E (ttm):N/A
    EPS (ttm):-0.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ┬╗ More Headlines for DCTH

    Comparison

    Symbol% ChgMkt Cap
    DCTHDown 10.62%5.56M
    LLYUp 0.75%79.03B
    PFEDown 0.50%204.99B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.12
    Quarterly EPS Est (Jun-16) :-0.19
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.02

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback